
Lawrence Okoye
Ask VT AI
View News Summary
- Vulcan Materials reports strong Q3 results, expects continued growth in construction materials demand driven by infrastructure spending.
- Novo Nordisk launches $9B bid to acquire U.S. obesity biotech Metsera, intensifying the race for next-generation weight-loss treatments.
- Novo Nordisk launches a rival $56.50 bid to acquire U.S. obesity biotech Metsera, challenging Pfizer's existing agreement and sparking a bidding war over Metsera's promising GLP-1 pipeline.
20 hours

United States Politics
Discover the latest news, candidates, and key topics of US politics
Ask VT AI
View News Summary
- Vulcan Materials reports strong Q3 results, expects continued growth in construction materials demand driven by infrastructure spending.
- Novo Nordisk launches $9B bid to acquire U.S. obesity biotech Metsera, intensifying the race for next-generation weight-loss treatments.
- Novo Nordisk launches a rival $56.50 bid to acquire U.S. obesity biotech Metsera, challenging Pfizer's existing agreement and sparking a bidding war over Metsera's promising GLP-1 pipeline.
20 hours

United States Politics
Discover the latest news, candidates, and key topics of US politics
Most Reported By
News from Lawrence Okoye
News from Lawrence Okoye
